Can Chinese Phase I data from the West accelerate China drug development?
The science of ethnobridging – a way to implement cost-effective, multi-ethnic approaches to global clinical trial research and drug development.
Related Insights
Article
Australia: A highly attractive environment for drug development
Aug 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Video
How early-stage diversity strategies can save time and budget later
Oct 3, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Lessons from China and the United States on the use of RWE in regulatory submissions
Jul 19, 2021
Blog
Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients
Sep 23, 2022
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Video
Importance of Diversity, Equity and Inclusion (DE&I) in medical communications
Jun 8, 2021
Blog
Population diversity: important considerations in vaccine development
Jun 14, 2023
Article
Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?
Jun 30, 2021
Blog
New Real World Evidence leader in Asia/Pacific returns to Parexel with lessons learned from China adventure
Jan 13, 2023
Blog
Xoli Belgrave appointed to lead Parexel’s Clinical Trial Diversity, Equity & Inclusion strategy
Jan 10, 2023
Related Insights
Article
Australia: A highly attractive environment for drug development
Aug 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Video
How early-stage diversity strategies can save time and budget later
Oct 3, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Lessons from China and the United States on the use of RWE in regulatory submissions
Jul 19, 2021
Blog
Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients
Sep 23, 2022
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Video
Importance of Diversity, Equity and Inclusion (DE&I) in medical communications
Jun 8, 2021
Blog
Population diversity: important considerations in vaccine development
Jun 14, 2023
Article
Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?
Jun 30, 2021
Blog
New Real World Evidence leader in Asia/Pacific returns to Parexel with lessons learned from China adventure
Jan 13, 2023
Blog
Xoli Belgrave appointed to lead Parexel’s Clinical Trial Diversity, Equity & Inclusion strategy
Jan 10, 2023